- Details
- Description
LuciNinted 150 mg (Nintedanib) is a prescription antifibrotic medicine used to slow the progression of certain chronic fibrosing lung diseases. Nintedanib is used in adults with idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung disease (ILD), and systemic sclerosis-associated interstitial lung disease (SSc-ILD), as prescribed by a healthcare professional.
Nintedanib works by inhibiting several tyrosine kinase pathways involved in the development and progression of fibrosis, helping to slow the decline of lung function.
Active Ingredient: Nintedanib 150 mg
Dosage Form: Oral capsule
Therapeutic Category: Antifibrotic agent
Prescription Status: Prescription medicine
Route of Administration: Oral
LuciNinted 150 mg should be taken exactly as directed by a healthcare professional, generally with food. Common adverse effects may include diarrhea, nausea, abdominal discomfort, decreased appetite, weight loss, and elevated liver enzymes. Liver function monitoring may be required during treatment.
